Texas Fertility Center
Get Started Today!

Kaylen Silverberg MD

Kaylen Silverberg MD provides world-class fertility care to help patients become parents

  • Kaylen Silverberg MD
    Kaylen Silverberg MD

  • For decades, Kaylen Silverberg MD has helped hopeful parents from all walks of life overcome the complex causes of infertility to start or grow their families. Texas Fertility Center (TFC) patients value the experience, knowledge and compassion of our award-winning Austin fertility doctor.

    His reach extends beyond the walls of TFC because he is an active researcher whose findings have improved the safety and effectiveness of fertility treatments around the United States and the world. He also helps train the next generation of fertility doctors in his role as a professor.

    Dr. Silverberg has impressive education and training

    Originally from Dallas, Kaylen Silverberg MD earned his undergraduate degree in molecular biology and business administration from Vanderbilt University. Our Austin fertility doctor then attended medical school at the Baylor College of Medicine.

    He returned to Vanderbilt University to complete an Obstetrics and Gynecology residency at the Vanderbilt University Medical Center. After his residency, he completed a fellowship in Reproductive Endocrinology and Infertility at the University of Texas Health Science Center in San Antonio.

    Kaylen Silverberg MD treats the complex causes of infertility

    Our Austin fertility doctor has served as the medical director of TFC since 1997. As a reproductive endocrinologist, Kaylen Silverberg MD works with women and men to diagnose and treat infertility using both basic and advanced treatments.

    • Ovulation induction
    • Intrauterine insemination (IUI)
    • In vitro fertilization (IVF)
    • Intracytoplasmic sperm injection (ICSI)
    • Donor sperm, egg and embryo services
    • Egg freezing

    Our Austin fertility doctor is also a highly trained and skilled surgeon who performs minimally invasive fertility surgery to treat endometriosis, fibroids, adhesions and ovarian cysts. Dr.  Silverberg  actively performs infertility research and has published extensive research in this area. One of his top areas of expertise is surgical and nonsurgical treatment endometriosis and pelvic adhesion prevention.

    To find out how Kaylen Silverberg MD can help you achieve your family-building goals, contact us to schedule an appointment. See the difference that experience makes in fertility care.

Meet Dr. Kaylen Silverberg

Fertility education videos by Dr. Kaylen Silverberg

  • Dr Silverberg on KVUE Austin Discusses A New Treatment for Endometriosis

  • Dr. Silverberg Interviewed About Artificial Intelligence in Fertility

  • Dr Silverberg Discusses Research by Texas Fertility Center on Premature Progesterone Production

  • Learn About Advocacy Day with Texas Fertility Center

Dr. Silverberg's fertility research

2015 Kaylen M Silverberg, Jocelyn Davie, Nicole Faulkner, Valerie Greger, Dana Neitzel. Carrier Screening for Spinal Muscular Atrophy Among U.S. In Vitro Fertilization Patients – Obstetrics and Gynecology (Impact Factor: 4.37). 05/2015; 125 Suppl 1:93S. DOI: 0.1097/01. AOG.0000463190.20503.3a – Presented at the 2015 Annual ACOG Meeting
2015 Kaylen M Silverberg, Valerie Greger, Dana Neitzel, Stephanie Hallam – Carrier Screening With Next-Generation Sequencing Detects Common, Uncommon, and Novel Mutations. Obstetrics and Gynecology (Impact Factor: 4.37). 05/2015; 125 Suppl 1:93S. DOI: 10.1097/01. AOG.0000463189.20503.ec
2014 Jocelyn Davie, Michael Alper, Valerie Baker, Angeline Beltsos, Bradford Kolb, Selwyn Oskowitz,Kaylen Silverberg, Andrew Toledo. – Next-generation DNA sequencing: improving the accuracy of routine carrier screening -Volume 101, Issue 2, Supplement, Page e35, February 2014
2013 Laurel Stadtmauer, M.D., Ph.D., Kaylen M. Silverberg, M.D.,Elizabeth S. Ginsburg, M.D., Herman Weiss, M.D., and Brandon Howard, Ph.D – Progesterone vaginal ring versus vaginal gel for luteal support with in vitro fertilization: a randomized comparative study – Fertil Steril 2013;99(3):605-952
2013 Hall A, Zain R, Silverberg KM, The institution of an active social media campaign increases new and returning web traffic and drives patient conversion. Presented at the 69th Annual Meeting of the American Society for Reproductive Medicine, Boston, MA, October, 2013
2013 Fields R, Werland H, Pogson K, Turner T, Silverberg KM. Laser collapsing of blastocysts prior to vitrification leads to better embryonic survival and improved overall IVF cycle outcome. Presented at the 69th Annual Meeting of the American Society for Reproductive Medicine, Boston, MA, October, 2013
2012 Silverberg KM, Howard B. Satisfaction with progesterone vaginal ring (PGN VR): Survey of women participating in a randomized trial of weekly PGN VR vs. 8% PGN gel as luteal support after in vitro fertilitzation (IVF). Presented at the 68th Annual Meeting of the American Society for Reproductive Medicine, San Diego, CA. October, 2012.
2012 Silverberg KM, Minter TL, Silverberg KM, Vaughn TC, Hansard LJ, Burger NZ. Both AMH and day 3 FSH levels predict IVF stimulation outcome regardless of patient age; Day 3 estradiol levels are not predictive. Presented at the 68th Annual Meeting of the American Society for Reproductive Medicine, San Diego, CA. October, 2012.
2012 Silverberg, K, Vaughn, T, Hansard, L, Burger, N and Minter, T. – Efficacy of a Progesterone Vaginal Ring versus Progesterone Gel for Luteal Phase Supplementation -Fertil Steril – VOL. 97 NO. 2 / February, 2012.
2012 Silverberg KM – Focus on Your Fertility: Now and for the Future – Jewish Outlook Health Guide, Jan 2012
2011 Fossum, G, Silverberg, K, Miller, C, Diamond, M, Holmdahl, L – Gynecologic Use of Sepraspray Adhesion Barrier – Fertil Steril Vol. 96, No. 2, August 2011
2011 Silverberg K., Howard B.- Efficacy of a progesterone vaginal ring versus progesterone gel for luteal phase supplementation – Presented at the Annual Meeting of the American College of Obstetricians and Gynecologists, Washington DC, 2011.
2011 Silverberg,K, Howard, B – Poster: Efficacy of a Progesterone Vaginal Ring versus Progesterone Gel for Luteal Phase Supplementation – Presented at the annual meeting of American College of OB/GYN, Washington DC, May 2011
2011 Silverberg K, Howard B. – Demonstration of efficacy of a novel progesterone vaginal ring compared to a daily progesterone gel for luteal phase supplementation after in vitro fertilization (IVF) – Presented at the Annual Meeting of the American College of Obstetricians and Gynecologists, Washington DC. May, 2011
2011 Silverberg K, Reape K, Howard B. – Efficacy of a progesterone vaginal ring versus progesterone gel for luteal phase supplementation by body mass index (BMI) – Presented at the 67th Annual Meeting of the American Society for Reproductive Medicine, Orlando, FL. October, 2011.
2011 Silverberg KM, Howard BK- Abstract: Efficacy of a Progesterone Vaginal Ring versus Progesterone Gel for Luteal Phase Supplementation - Presented at the Annual meeting of American College of OB/GYN in Washington DC May 2011
2011 Plante M, Smith E B, Cox S, Silverberg K, Reich S- The case of a viable pregnancy post vaginal radical trachelectomy followed by combined chemo-radiation therapy– Gynecologic Oncology YGYNO-974169; No. of pages: 3; 4C 2011

Papers

2020 VerMilyea M, Dakka M, Hall J, Diakiw S, Nguyen T, Perugini D, Silverberg K, Perugini M. Evidence for superior blastocyst cohort ranking using artificial intelligence based on retrospective clinical pregnancy results. Repro BioMed Online.2020.
2019 Munne S, Kaplan B, Frattarelli J, Silverberg K, et al. Preimplantation genetic testing for aneuploidy: a pragmatic multicenter randomized clinical trial of single frozen euploid embryo transfer vs. selection by morphology alone. Repro BioMed Online. 2019. 38(1): 9
2019 Wilman S, Munne S, Kaplan B, Shamma F, Silverberg K, Handyside A, et al. Preimplantation genetic testing for aneuploidy vs. morphology as selection criteria for single frozen embryo transfer in good prognosis patients: a multicenter, randomized trial. Fertil Steril 2019.
2018 Ginsburg E, Jellerette-Nolan T, Daftary G, Du Y, Silverberg K. Patient experience in a randomized trial of a weekly progesterone vaginal ring vs a daily progesterone gel for luteal support following in vitro fertilization. Fertil Steril. 2018. 110:6;1101-8.
2014 Shapiro D, Boostanfar R, Silverberg K, Yanushpolsky E. Examining the evidence: Progesterone supplementation during fresh and frozen embryo transfer. Repro Biomed Online. 2014;29:S1-14.
2012 Silverberg K, Vaughn TC, Hansard LJ, Burger NZ, Minter T. Vaginal (Crinone 8%) gel vs intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial. Fertil Steril, 97:344-8, 2012
2010 Boswell K, Silverberg K. Reoccurrence of Ovarian Torsion in a Multiple Pregnancy: Conservative Management via Transabdominal Ultrasound Guided Ovarian Cyst Aspiration. Fertil Steril, 94:1910-13, 2010.
2009 Szyller A, Silverberg K, Crumb R, Vaughn T, Hansard L, Burger N. Ovarian stromal vascularity evaluated by Doppler correlates with the dose of FSH used during stimulation for IVF-ET. Fertil Steril, 92:S47-8, 2009.
2009 Miller C, Fossum G, Diamond M, Silverberg K, Holmdahl L. Reduction of postoperative adhesions with Sepraspray: A phase II pilot study. J Min Invasive Gyn. 2009.16:S14-15.
2009 Diamond MP, Fossum GT, Silverberg KM, Miller CE, Holmdahl L, Sepraspray Study Group. Sepraspray, a new option for reduction of postoperative adhesions. Fertil Steril, 92:S59, 2009.
2009 Silverberg KM, Meletiche D, De la Rosa G. An employer’s experience with infertility coverage: A case study. Fertil Steril, 92:2103-5, 2009.
2009 James S, Silverberg KM, Hansard LJ, Burger NZ, Vaughn TC. Rare mullerian anomaly commonly misdiagnosed. Fertil Steril, in press, 2009
2008 Silverberg KM. Pelvic Adhesions: Prevention through adjunctive therapies. OBG Management. Suppl, Sept., 2008.
2006 Brown C, Luciano A, Martin D, Silverberg, et al. Adept (Icodextrin4% Solution) reduces adhesions after laparoscopic surgery for adhesiolysis: A double-blind, randomized, controlled study. Fertil Steril 12;84-97, 2006.
2004 Garcia J, Kettel LM, Klein N, Silverberg KM, et al. An Aqueous Formulation of Recombinant FSH is More Efficient Than a Freeze-Dried Cake Formulation in Clomiphene-Resistant Women With Chronic Anovulation. Today’s Therapeutic Trends 22 (3):147-165, 2004.
2003 Daya S, Wikland M, Silverberg K, et al. Quality of life (QOL) differentiation analysis in patients undergoing controlled ovarian stimulation (COS) with two different preparations of recombinant human follicle-stimulating hormone (r-hFSH). Fertil Steril 80:137-42, 2003.
2002 Gambone JC, Mittman BS, Windel CA, Silverberg KM, et al. Consensus Statement for the management of chronic pelvic pain and endometriosis: Proceedings of an expert-panel consensus process. Fertil Steril 78:961-72, 2002.
2002 Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 78;699-704, 2002
2002 Silverberg K, Schertz J, Falk B, Beresniak A. Impact of urinary FSH price: a cost effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA. Reprod Biomed Online Nov/Dec.5 (3) 265-9, 2002.
2002 Silverberg K. Issues of bioequivalence and cost equivalence. Fertil Steril 78 (2):438-40, 2002
2002 Silverberg K, Daya S, Auray JP, Duru G, Ledger W, Wikland M, Bouzayen R, O’Brien M, Falk B, Beresniak A: Analysis of the cost effectiveness of recombinant versus urinary follicle stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States. Fertil Steril, 77(1) 107-13, 2002
2001 Diamond M, Bieber E, Silverberg K, et al. Pelvic adhesions and Pelvic pain: opinions on cause and effect relationship and when to surgically intervene. Gynecological Endoscopy 10:211-16, 2001
2001 Daya S, Ledger W, Auray JP, Duru G, Silverberg K, Wikland M, et al. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK. Hum Reprod. 16(12):2563-9, 2001
2001 Diamond, MP, Silverberg KM, et al: Serum Electrolytes, Chemistries, and Blood Cell Counts after Gynecologic Surgery in Healthy Women. J Gynecol Tech. 2001.
1998 Scott RT, Silverberg KM: Ethics of Guaranteeing Patient Outcomes: A Complex Issue Whose Time Has Not Come. Fertil Steril 70:422-24, 1998.
1998 Diamond MP, Backus K, Silverberg KM, et al: Reduction of de novo Postsurgical Adhesions by Intraoperative Precoating With Sepracoat (HAL-C) Solution: A Prospective, Randomized, Blinded, Placebo-Controlled Multicenter Study. Fertil Steril 69:1067-74, 1998.
1998 Meldrum, DR, Silverberg KM, Bustillo M, Stokes L: Success Rate With Repeated Cycles of IVF-ET. Fertil Steril, 69:1005-9, 1998
1996 Silverberg, KM: Ovulation Induction in the Ovulatory Woman. Sem Reprod Endocrinol, 14(4):339, 1996.
1996 Diamond MP, Bachus K, Bieber E, Bradshaw K, Gallup D, Grunert G, Mok A, Morris R, Perez R, Radwanska E, Silverberg KM, Steinkampf M, Halpern E, Fleming L, Easton C: Comparison of the Reproducibility of Two Standardized Adhesion Scoring Methods. Fertil Steril, 1996
1995 Stovall TG, Muneyyirci-Delale O, Summitt RL, Silverberg K, et al: GnRH Agonist and Iron Versus Placebo and Iron in the Anemic Patient Before Surgery for Leiomyomas: A Randomized Controlled Trial. Obstet Gynecol 86:65, 1995.
1994 Burns WN, Silverberg KM, Klein NA, Witz CA, Schenken RS: Serum Progesterone Concentrations on the Day After Human Chorionic Gonadotropin Administration and Progesterone/Oocyte Ratios Predict in Vitro Fertilization/Embryo Transfer Outcome. J Assist Reprod Genet 11:700, 1994
1994 Silverberg KM, Martin M, Olive DL, Burns WN, Schenken RS: Elevated Serum Progesterone Levels on the Day of hCG Administration in IVF Cycles do not Adversely Affect Embryo Quality: Analysis of Subsequent Frozen Embryo Transfers. Fertil Steril 61:508, 1994
1993 Silverberg KM, Dey TD, Witz CA, Schenken RS: D-Mannose Binding Provides a More Objective Assessment of Male Fertility Than Routine Semen Analysis: Correlation With in Vitro Fertilization. Fertil Steril, Submitted.
1993 10. Witz CA, Silverberg KM, Burns WN, Schenken RS, Olive DL: Complications Associated With the Absorption of Hysteroscopic Fluid Media. Fertil Steril 60:745, 1993
1992 Silverberg KM, Klein NA, Burns WN, Schenken RS, Olive DL: Consecutive Versus Alternating Cycles of Controlled Ovarian Hyperstimulation with Human Menopausal Gonadotropin. Hum Reprod 7:940, 1992
1992 Silverberg KM, Johnson JV, Olive DL, Burns WN, Schenken RS: A Prospective, Randomized Trial Comparing Two Different Intrauterine Insemination Regimens in Controlled Ovarian Hyperstimulation Cycles. Fertil Steril 57:357, 1992
1991 Silverberg KM, Burns WN, Olive DL, Riehl RM, Schenken RS: Serum Progesterone Levels Predict Success of in Vitro Fertilization/Embryo Transfer. J Clin Endocrinol Metab 73:797, 1991
1991 Silverberg KM, Olive DL, Schenken RS: Progesterone Levels on the Day of Human Chorionic Gonadotropin Administration in Cycles With Gonadotropin-Releasing Hormone Agonist Suppression Are Not Predictive of Pregnancy Outcome. (Letter to the Editor). Fertil Steril 56:153, 1991
1991 Silverberg KM, Olive DL, Burns WN, Johnson JV, Groff TR, Schenken RS: Follicular Size at the Time of Human Chorionic Gonadotropin Administration Predicts Ovulation Outcome in Human Menopausal Gonadotropin-Stimulated Cycles. Fertil Steril 56:296, 1991
1991 Silverberg KM, Hill GA: Reproductive Surgery vs. Assisted Reproductive Technologies: Selecting the Correct Alternative. J Gynecol Surg 7:67, 1991
1990 Silverberg KM, Boehm FH: Hemophilus Influenza Amnionitis With Intact Membranes: A Case Report. Am J Perinatol 7:270, 1990
1990 Falk RM, Silverberg KM, Fetterolf PM, Kirchner FK, Rogers BJ: Establishment of Test-Yolk Buffer Enhanced SPA Limits for Fertile Males. Fertil Steril 54:121, 1990
1990 Silverberg KM, Olive DL, Schenken RS: Ovarian Cyst Aspiration Prior to Initiating Ovarian Hyperstimulation for in vitro fertilization. J. In Vitro Fert Embryo Transf 7:153, 1990

Abstracts

2020 VerMilyea MD, Dakka MA, Hall J, Diakiw SM, Nguyen T, Perugini D, Silverberg K, Perugini M. Evidence for superior blastocyst cohort ranking using artificial intelligence based on retrospective clinical pregnancy results. To be presented at the 76th Annual meeting of the American Society for Reproductive Medicine, Portland, OR, October, 2020.
2020 Dakka MA, VerMilyea MD, Nguyen T, Perugini D, Silverberg K, Diakiw SM, Hall J, Perugini M. Identifying inherent poor quality embryo viability data using artificial intelligence to improve AI performance and clinical reporting. To be presented at the 76th Annual meeting of the American Society for Reproductive Medicine, Portland, OR, October, 2020.
2019 Yu S, Silverberg K, Bhagavath B, Shobeiri A, Propst A, Eisenstein D. Post-market surgeon safety outcomes and experience performing laparoscopic ultrasound guided radiofrequency ablation using the Acessa system. Presented at the 48th Annual meeting of the American Association of Gynecologic Laparoscopy/Global congress on minimally invasive gynecologic surgery, Vancouver BC, Canada, November, 2019
2019 Munne S, Kaplan B, Frattarelli J, Silverberg K, et al. Preimplantation genetic testing for aneuploidy vs. morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter prospective randomized trial. Presented at the 75th Annual meeting of the American Society for Reproductive Medicine, Philadelphia, PA, October, 2019.
2019 Picou A, Werland H, Staha A, Silverberg K, VerMilyea M. Keep or Toss? A retrospective evaluation of the benefits of culturing blastocysts obtained from 0PN/1PB zygotes. Presented at the 75th Annual meeting of the American Society for Reproductive Medicine, Philadelphia, PA, October, 2019
2019 Picou A, Werland H, Silverberg K, VerMilyea M. Blastocyst formation and pregnancy rate comparison between standard large box incubators and a novel Geri time-lapse incubator. Presented at the 75th Annual meeting of the American Society for Reproductive Medicine, Philadelphia, PA, October, 2019
2019 Lee D, Silverberg K, Hongyu M, Picou A, Garcia C, Propst A. The endometrial receptivity analysis does not increase live birth rates in first time frozen embryo transfer with euploid blastocysts. Presented at the 75th Annual meeting of the American Society for Reproductive Medicine, Philadelphia, PA, October, 2019
2019 VerMilyea MD, Hall J, Perugini D, Silverberg K et al. Artificial intelligence: non-invasive detection of morphological features associated with abnormalities in chromosomes 21 and 16. Presented at the 75th Annual meeting of the American Society for Reproductive Medicine, Philadelphia, PA, October, 2019
2018 Picou A, Cutler K, Silverberg K, VerMilyea M. Prospective observational, comparative and validation study using a timelapse morphometry MIRI imaging incubator. Presented at the 74th Annual meeting of the American Society for Reproductive Medicine, Denver, CO, October, 2018.
2018 Rios CM, Whitney JB, VerMilyea M, Jones A, Picou A, Balloch K, Nugent N, Silverberg K, Anderson RE, Schiewe MC. Increased scrutiny of NGS profiles/ranking does not improve eSET implantation of euploid blastocysts: A randomized comparative trial. Presented at the Annual Meeting of the European Society for Human Reproduction and Embryology. Barcelona, Spain, July, 2018
2018 Miller A, Rios C, Silverberg K, VerMilyea M. Euploid rate of embryos derived from aspirated and ejaculated sperm. Presented at the Annual Meeting of the European Society for Human Reproduction and Embryology. Barcelona, Spain, July, 2018.
2017 Werland H, VerMilyea M, Silverberg K. Culturing embryos to Day 7. A viable option for IVF patients? Presented at the 73rd Annual Meeting of the American Society for Reproductive Medicine, San Antonio, TX, October, 2017.
2017 53. Propst A, Hansard L, Silverberg K, Hegtvedt M, Burger N, Vaughn T. Endometrial receptivity and pregnancy rates are higher after 7 days of progesterone in medicated FET cycles. Presented at the 73rd Annual Meeting of the American Society for Reproductive Medicine, San Antonio, TX, October, 2017.
2017 Rios C, Baker W, Aguirre M, Silverberg K, VerMilyea M. An initial review of next generation screening: A new service provider for comprehensive chromosomal screening (CCS) by next generation sequencing (NGS). Presented at the 73rdAnnual Meeting of the American Society for Reproductive Medicine, San Antonio, TX, October, 2017.
2017 Gavrizi S, Silverberg B, Silverberg K. Examining the luteal placental shift in pregnancy following frozen embryo transfer. Presented at the 73rd Annual Meeting of the American Society for Reproductive Medicine, San Antonio, TX, October, 2017.
2017 Munne S, Kaplan B, Silverberg K, et al. Global multicenter randomized controlled trial comparing single embryo transfer with embryo selected by preimplantation genetic screening using next-generation sequencing versus morphologic assessment. Presented at the 73rd Annual Meeting of the American Society for Reproductive Medicine, San Antonio, TX, October, 2017.
2016 VerMilyea M, Werland H, Sieren K, Silverberg K. Day 5, 6, and 7 blastocyst ploidy status stratified by patient age. Presented at the 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October, 2016.
2016 Picou A, VerMilyea M, Werland H, Sieren K, Silverberg K. Blastocyst morphology is a poor indicator of euploid status. Presented at the 72nd Annual Meeting of the American Society for Reproductive Medicine, Salt Lake City, UT, October, 2016.
2015 Picou A, Hellmers A, Werland H, Turner T, Silverberg K. A comparison of pregnancy rates of frozen embryo transfers of vitrified blastocysts to vitrified euploid blastocysts. Presented at the 71st Annual Meeting of the American Society for Reproductive Medicine, Baltimore, MD, October, 2015.
2015 Silverberg K, Neitzel D, Greger V, Hallam S. Carrier screening with next-generation sequencing detects common, uncommon, and novel mutations. Presented at the 2015 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists, San Francisco, CA, May, 2015.
2010 Vaughn T, Silverberg K, Hansard L, Burger N. Selection of Young Patients Using Strict Criteria Allows an Excellent Chance of Pregnancy When Transferring a Single Embryo While Avoiding a High Risk of Multiple Gestation. Presented at the 66th Annual Meeting of the American Society for Reproductive Medicine, Denver, CO. October, 2010
2010 Silverberg K, Vaughn T, Hansard L, Burger N, Minter T. Progesterone Vaginal Gel vs. Intramuscular Progesterone in Oil for Luteal Support in IVF: A Large, Prospective Trial. Presented at the 66th Annual Meeting of the American Society for Reproductive Medicine, Denver, CO. October, 2010
2010 Szyller A, Silverberg K, Crumb R, Vaughn C, Hansard L, Burger N. A Prospective, Observational, Comparative Single Center Trial to Predict In Vitro Fertilization and Embryo Transfer Outcome by Ovarian Ultrasound Doppler Measurements. Annual Meeting of the American Institute of Ultrasound In Medicine, San Diego, CA, March, 2010.
2009 Szyller A, Silverberg K, Crumb R, Vaughn T, Burger N, Hansard L. Ovarian Stromal Vascularity Evaluated By Doppler Correlates With The Dose Of FSH Used During in vitro fertilization(IVF) Stimulation. Presented at the 65th Annual Meeting of the American Society for Reproductive Medicine, Atlanta, GA. October, 2009.
2007 Turner T, Fields R, Werland H, Hansard L, Vaughn T, Silverberg K. Determining the Predictive Value of Day 3 Embryonic Morphology and Cell Stage on Ultimate Embryo Quality. Presented at the 63rd Annual Meeting of the American Society for Reproductive Medicine, Washington, DC. October 16, 2007.
2007 Fields R, Turner T, Werland H, Pogson K, Vaughn T, Silverberg K. Can We Predict Blastocyst Viability Based on Day 3 Embryo Development? Presented at the 63rd Annual Meeting of the American Society for Reproductive Medicine, Washington, DC. October 15, 2007.
2007 Luna M, Martinuzzi K, Silverberg K, Treiser S, Kolb B, Copperman AB. Elective Oocyte Cryopreservation for Fertility Preservation: A National Perspective. Presented at the 2007 Meeting of the American College of Obstetricians and Gynecologists, San Diego, CA, May 8, 2007.
2006 Silverberg KM, Minter TM, Basuray R. Gonal F-RFF vs. Gonal F Multi-Dose for IVF Stimulation: A Prospective, Sequential Trial. Presented at the 62nd Annual Meeting of the American Society for Reproductive Medicine, New Orleans, LA, October 22, 2006.
2006 Silverberg KM, Minter TM, Vaughn TC. Recombinant FSH Alone vs. Combination FSH/LH Stimulation: A Prospective Trial. Presented at the 62nd Annual Meeting of the American Society for Reproductive Medicine, New Orleans, LA, October 22, 2006.
2006 Silverberg KM, Werland H, Turner T, Fields R, Crowl C, Hansard LJ, Vaughn TC. Determining the Predictive Value of Day 3 Embryonic Morphology and Cell Stage on Ultimate Embryo Quality. Presented at the 62nd Annual Meeting of the American Society for Reproductive Medicine, New Orleans, LA, October 22, 2006.
2005 Silverberg KM, Werland H, Turner T, Fields R, Schuster C, Hansard LJ, Vaughn TC. Choosing the optimal incubator environment: triple gas vs. 5% CO2 in air, a prospective, randomized trial. Presented at the 61st Annual Meeting of the American Society for Reproductive Medicine, Montreal, Canada, October 16, 2005.
2005 Silverberg KM, Werland H, Turner T, Fields R, Schuster C, Hansard LJ, Vaughn TC. Suboptimal embryo morphology on day 3 does not predict poor pregnancy potential. Presented at the 61st Annual Meeting of the American Society for Reproductive Medicine, Montreal, Canada, October 18, 2005.
2004 Silverberg KM, Minter T, Hansard LJ, Vaughn TC. High order multiples and gonadotropin/IUI cycles: how can we reduce the risks? Presented at the 60th Annual Meeting of the American Society for Reproductive Medicine, Philadelphia, PA, October 20, 2004.
2003 Daya S, Wikland M, Silverberg K, Blatz S, Duru G, Beresniak A. Quality of life (QOL) differentiation analysis in patients undergoing controlled ovarian stimulation (COS) with two different preparations of recombinant human follicle-stimulating hormone (r-hFSH). Presented at the 59th Annual Meeting of the American Society for Reproductive Medicine, San Antonio, Texas, USA, October 11-15, 2003
2001 Silverberg KM, Ormand R, Hansard LJ, Vaughn TC. Recombinant FSH Provides More Efficient, Cost-Effective Stimulation for Ovulation Induction/Intrauterine Insemination (OI/IUI) Cycles Than Highly Purified Urinary FSH. Presented at the 57th Annual meeting of the American Society for Reproductive Medicine. Orlando, FL. October, 2001.
2001 Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. The effect of prolonged GnRH agonist therapy on in vitro fertilization-embryo transfer cycle outcome in endometriosis patients: a multicenter randomized trial. Presented at the 57th Annual meeting of the American Society for Reproductive Medicine. Orlando, FL. October, 2001.
2001 Silverberg KM, Ormand R, Hansard LJ, Vaughn TC. Poor Response to Ovarian Hyperstimulation Predicts Spontaneous Ovulation. Presented at the 57th Annual meeting of the American Society for Reproductive Medicine. Orlando, FL. October, 2001.
2001 Silverberg KM, Schertz J, Falk B, Beresniak A. Impact of Price Variability on Cost-Effectiveness Modeling of rFSH Vs. uFSH in ART in the United States. Presented at the 2nd Annual Controversies in OB/GYN and Infertility Meeting, Paris, France, September, 2001.
2000 Silverberg KM, Ormand RA, Hansard LJ, Vaughn TC. Weight Correlates with Gonadotropin Requirements and Patient Response. Presented at the 56th Annual meeting of the American Society for Reproductive Medicine, San Diego, California. October, 2000.
2000 Montgomery-Rice V, Silverberg K, Karst A, Ormand R, et al. Patient Tolerance to Recombinant Human Follicle Stimulating Hormone (r-hFSH, Gonal-F®) and Leuprolide Acetate (LA, Lupron®) Administered in Single or Separate Injections in Women Undergoing IVF; Preliminary Results. Presented at the 56th Annual meeting of the American Society for Reproductive Medicine, San Diego, California. October, 2000.
2000 Diamond MP, Tedford CE, Silverberg KM, et al. Assessment of Pelvic Adhesions: Statistical Validation, Reliability and Interobserver Correlation Using a Modification of the More Comprehensive Adhesion Scoring Method (MCASM). Presented at the 56th Annual meeting of the American Society for Reproductive Medicine, San Diego, California. October, 2000.
2000 Silverberg KM, Ormand RA, Hansard LJ, and Vaughn TC: The Intercycle Variability in Patients Treated With Repeated Cycles of Gonadotropins is Due to Intrinsic Factors and is Not Eliminated by Recombinant Gonadotropins. Presented at the 56th Annual meeting of the American Society for Reproductive Medicine, San Diego, California. October, 2000
2000 Silverberg KM, Montgomery Rice V, Ormand R, Karst A, Vaughn T, Hansard L: Recombinant Human Follicle Stimulating Hormone (rFSH, Gonal-F) and Leuprolide Acetate (LA, Lupron) Administered in Single or Separate Injections in Women Undergoing in vitro Fertilization (IVF): Preliminary Results. Presented at the Annual Meeting of the European Society of Human Reproduction and Endocrinology. Bologna, Italy, June 25, 2000.
1999 \Silverberg KM, Ormand RA, Hansard LJ, and Vaughn TC: Clomiphene Citrate Improves Sperm Quality and Fertility in Hypogonadal, Oligospermic Males. Presented at the 55th Annual meeting of the American Society for Reproductive Medicine. Toronto, Canada, September 27, 1999.
1999 Silverberg KM, Ormand RA, Hansard LJ, Turner T, Slapak J, Williamson B, and Vaughn TC: Ultra-low Dose Lupron Flare Offers Improved Outcome for Poor Responders. Presented at the 55th Annual meeting of the American Society for Reproductive Medicine. Toronto, Canada, September 25, 1999.
1999 Kelly E, Silverberg KM, et al: Recombinant FSH Therapy Alone (Gonal-F) Versus Combination Therapy (Gonal-F + LHadi) in Patients Down Regulated With Low Dose Luteal GnRH Agonist Protocol: Preliminary Results”. Presented at the 11th World Congress on In Vitro Fertilization, Sydney, Australia, May 9-14, 1999.
1996 Diamond MP, Silverberg KM, et al: Precoating with Sepracoat (HAL-C) Reduces Postoperative De Novo Adhesion Formation In A Multicenter Randomized, Placebo-Controlled Gynecologic Clinical Trial. Presented at the 43rd Annual Meeting of the Society for Gynecologic Investigation, Philadelphia, PA, March 20-23, 1996.
1995 Diamond MP, Ackerman G, Silverberg KM, et al: Adhesions: Effect on pregnancy outcome. Presented at the World Congress of Gynecologic Endoscopy, Orlando, Florida, November 7-12, 1995.
1995 Silverberg KM, Dey T: The avidin biotin complex D-mannose binding assay predicts fertilization in vitro. Presented at the Annual Meeting of the Pacific Coast Fertility Society, Coronado, California, April 26-30, 1995.
1995 Silverberg KM, Awadalla SG, Grainger D, Jacobson A, Katayama P, Kenigsberg D, et al: A phase 3, open-label, multicenter study to evaluate the safety and efficacy of Metrodin XP for in vitro fertilization. Presented at the 9th World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, Austria, April 3-7, 1995.
1995 Silverberg KM, Dey T: The mannose-binding assay is more reproducible than sperm concentration, motility, or morphology. Presented at the Annual Meeting of the American Society of Andrology, Raleigh, North Carolina, April 2-5, 1995.
1993 Diamond MP, Bachus K, Bieber E, Bradshaw K, Gallup D, Grunert G, Mok A, Morris R, Perez R, Radwanska E, Silverberg KM, Steinkampf M, Halpern E, Fleming L, and Easton C: Comparison of the reproducibility of two standardized adhesion scoring methods. Presented at the combined 49th Annual Meeting of the American Fertility Society and the 39th Annual Meeting of the Canadian Fertility and Andrology Society, Montreal, Canada, October 9-14, 1993.
1993 Silverberg KM, Dey T, Witz CA, and Schenken RS: The modified D-Mannose in vitro binding assay (MBA) predicts fertilization in vitro. Presented at the combined 49th Annual Meeting of the American Fertility Society and the 39th Annual Meeting of the Canadian Fertility and Andrology Society, Montreal, Canada, October 9-14, 1993.
1993 Silverberg KM, Dey T, and Schenken RS: D-Mannose in vitro binding predicts in vitro fertilization. Presented at the 40th Annual Meeting of the Society for Gynecologic Investigation, Toronto, Canada, March 31-April 3, 1993.
1992 Silverberg KM, Martin M, Olive DL, Burns WN, and Schenken RS: Elevated serum progesterone levels on the day of hCG administration in IVF cycles do not adversely affect embryo quality: Analysis of subsequent frozen embryo transfers. Presented at the 48th Annual Meeting of the American Fertility Society, New Orleans, LA, October 31-November 5, 1992.
1992 Olive DL, Silverberg KM, Klein NA, and Burns WN: A comparison of study design methods for cycle-specific treatments of infertility. Presented at the 48th Annual Meeting of the American Fertility Society, New Orleans, LA, October 31-November 5, 1992.
1992 Silverberg KM, Dey T, Olive DL, and Schenken RS: Sperm antibodies induce the acrosome reaction in human spermatozoa in vitro. Presented at the 48th Annual Meeting of the American Fertility Society, New Orleans, LA, October 31-November 5, 1992.
1991 Silverberg KM, Klein NA, Burns WN, Schenken RS, and Olive DL: Consecutive versus alternating cycles of controlled ovarian hyperstimulation. Presented at the 47th Annual Meeting of the American Fertility Society, Orlando, FL, October 19-24, 1991.
1991 Silverberg KM, Burns WN, Olive DL, and Schenken RS: The significance of serum progesterone: estradiol ratios on the day of human chorionic gonadotropin administration in IVF/ET cycles. Presented at the 47 Annual Meeting of the American Fertility Society, Orlando, FL, October 19-24, 1991.
1991 Silverberg KM, Burns WN, Olive DL, and Schenken RS: Serum progesterone levels on the day of hCG administration predict success in cycles of controlled ovarian hyperstimulation. Presented at the 38th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, TX, March 20-23, 1991, A# 477, p.337.
1990 Silverberg KM, Olive DL, Riehl RM, and Schenken RS: Serum progesterone levels are a critical indicator of premature luteinization and pregnancy outcome in an IVF/ET cycle. Presented at the 46th Annual Meeting of the American Fertility Society, Washington, DC, October 13-18, 1990, A# P-118, p.114.
1990 Silverberg KM, Johnson JV, Olive DL, and Schenken RS: A prospective randomized trial to determine the optimal timing of intrauterine insemination following hCG administration after controlled ovarian hyperstimulation. Presented at the 46th Annual Meeting of the American Fertility Society, Washington, DC, October 13-18, 1990, A# P-082, p.100.
1990 Silverberg KM, Olive DL, and Schenken RS: Does follicular size at the time of hCG administration predict ovulation outcome? Presented at the 46th Annual Meeting of the American Fertility Society, Washington, DC, October 13-18, 1990, A# O-027, p.12.
1990 Silverberg KM, Groff TR, Riehl RM, Harper MJK, Olive DL, and Schenken RS: Platelet activating factor does not enhance the motility of fresh or cryopreserved human sperm. Presented at the 37th Annual Meeting of the Society for Gynecologic Investigation, St. Louis, MO, March 21-24, 1990, A258, p.225.
1988 Falk RM, Silverberg KM, Fetterolf PM, Kirchner FK, and Rogers BJ: Establishment of test-yolk buffer enhanced SPA limits for fertile males. Presented at the 44th Annual Meeting of the American Fertility Society, Atlanta, GA, October 10-13, 1988, A# P-12, p.48.

Awards

2013 Star Award-American Society for Reproductive Medicine
2012 Certificate of Appreciation-Department of the U.S. Army
2011 ASRM Service Award
2009 Austin Healthcare Heroes Nominee
2008 Finalist, Distinguished Surgeon of the Year – Association of Operating Room Nurses, Austin Chapter
2008-Present Patient Choice Award
2007-Present America’s Top Obstetricians and Gynecologists
2005 Family Building Award- American Fertility Association (National)
2004-Present Texas Super Doctors
2003-Present Best Doctors in Texas
2002-Present Doctors Across America – Top Doctors
2002-Present Best Doctors in Austin
2000 Prize Paper Award, Society of Reproductive Surgeons
2000 Outstanding Speaker Award, American Association of Clinical Chemistry
1999-Present International Who’s Who of Executives and Professionals
1995-Present Best Doctors in America
1991 Mead Johnson Laboratories/American College of Obstetricians & Gynecologists Focus on Patient Education Award
  • Patient's Choice Award
  • Super Doctors Texas
  • Super Doctors Texas Hall of Fame
  • Austin Top Doctors
  • Texas Doctor Badge 2019